Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Newly Diagnosed Glioblastoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00458601
What this trial is testing

Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme

Who this might be right for
Malignant Glioma
Celldex Therapeutics 82
Testing effectiveness (Phase 2)UnknownNCT02663440
What this trial is testing

Trial of Hypofractionated Intensity Modulated Radiation Therapy With Temozolomide and Granulocyte-macrophage Colony-stimulating Factor for Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Zhejiang Cancer Hospital 41
Testing effectiveness (Phase 2)Looking for participantsNCT07185880
What this trial is testing

The Safety and Tolerability of MT-125 in GBM Patients

Who this might be right for
Glioblastoma (GBM)
Myosin Therapeutics Inc. 36
Early research (Phase 1)Study completedNCT02311920
What this trial is testing

Ipilimumab and/or Nivolumab in Combination With Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma

Who this might be right for
GliosarcomaSupratentorial Glioblastoma
National Cancer Institute (NCI) 32
Testing effectiveness (Phase 2)Ended earlyNCT00005856
What this trial is testing

Oxaliplatin in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma
National Cancer Institute (NCI) 59
Not applicableStudy completedNCT00253669
What this trial is testing

Risk Factors for Developing a Blood Clot in Patients Who Are Undergoing Cancer Treatment for Newly Diagnosed Gliomas

Who this might be right for
Brain and Central Nervous System TumorsThromboembolism
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 110
Testing effectiveness (Phase 2)Looking for participantsNCT07225621
What this trial is testing

Adjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound Sonodynamic Therapy System for Newly Diagnosed Glioblastoma

Who this might be right for
GlioblastomaGBM
Alpheus Medical, Inc. 103
Early research (Phase 1)Study completedNCT00003409
What this trial is testing

Motexafin Gadolinium Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Jonsson Comprehensive Cancer Center
Early research (Phase 1)Ended earlyNCT00110032
What this trial is testing

Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain Tumors

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+24 more
National Cancer Institute (NCI) 46
Not applicableUnknownNCT05515133
What this trial is testing

Correlation Between Psychological Stress and Disease Progression in Newly Diagnosed Glioblastoma Patients

Who this might be right for
Glioblastoma
Henan Provincial People's Hospital 60
Testing effectiveness (Phase 2)Study completedNCT00187486
What this trial is testing

Safety and Efficacy Study of Tarceva, Temodar, and Radiation Therapy in Patients With Newly Diagnosed Brain Tumors

Who this might be right for
Glioblastoma MultiformeGliosarcoma
University of California, San Francisco 66
Testing effectiveness (Phase 2)Study completedNCT00003456
What this trial is testing

Antineoplaston Therapy in Treating Patients With Newly-diagnosed Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme of Brain
Burzynski Research Institute 40
Early research (Phase 1)Study completedNCT05376800
What this trial is testing

Determine How BI 907828 (Brigimadlin) is Taken up in the Tumor (Phase 0) and to Determine the Highest Dose of BI 907828 (Brigimadlin) That Could be Tolerated (Phase 1a) in Combination With Radiation Therapy in People With a Brain Tumor Called Glioblastoma

Who this might be right for
Glioblastoma
Boehringer Ingelheim 24
Early research (Phase 1)Study completedNCT03619239
What this trial is testing

Dose-escalation Study to Evaluate the Safety and Tolerability of GX-I7 in Patients With Glioblastoma

Who this might be right for
Newly Diagnosed Glioblastoma
Genexine, Inc. 15
Early research (Phase 1)Active Not RecruitingNCT03223103
What this trial is testing

Safety and Immunogenicity of Personalized Genomic Vaccine and Tumor Treating Fields (TTFields) to Treat Glioblastoma

Who this might be right for
Glioblastoma
Adilia Hormigo 13
Early research (Phase 1)Looking for participantsNCT07343986
What this trial is testing

Study of Low-Intensity Focused Ultrasound in Combination With Immunotherapy in Newly Diagnosed Unmethylated Glioblastoma

Who this might be right for
Glioblastoma (GBM)
University of Virginia 12
Testing effectiveness (Phase 2)Study completedNCT00445965
What this trial is testing

Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer

Who this might be right for
Brain and Central Nervous System TumorsIntraocular MelanomaLung Cancer+7 more
Memorial Sloan Kettering Cancer Center 78
Testing effectiveness (Phase 2)Active Not RecruitingNCT04574856
What this trial is testing

Multiparametric MR-Guided High Dose Adaptive Radiotherapy With Concurrent Temozolomide in Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
University of Michigan Rogel Cancer Center 30
Testing effectiveness (Phase 2)Ended earlyNCT00068770
What this trial is testing

Celecoxib in Patients With Newly Diagnosed GBM Who Are Receiving Anticonvulsant Drugs and Undergoing RT

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 35
Testing effectiveness (Phase 2)Study completedNCT00553150
What this trial is testing

Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Brain and Central Nervous System Tumors
Alliance for Clinical Trials in Oncology 122
Next Page